Abstract: The invention relates to a wireless access telecommunications system comprising at least an SA-cell with which a terminal in an active mode is configured to have a data connection and an LA-cell on which the terminal in an idle mode is configured to camp. A method for the terminal to at least obtain LA-cell system information and SA-cell system information includes, when the terminal is in the active mode and an SA-cell radio interface of the terminal is enabled, the terminal receiving at least a part of the SA-cell system information for the terminal from the SA-cell via the SA-cell radio interface. The method further includes enabling an LA-cell radio interface of the terminal during one or more of a plurality of LA time periods and receiving at least a part of the LA-cell system information for the terminal from the LA-cell via the LA-cell radio interface.

Abstract: The invention provides compounds of Formula 1: or a stereoisomer, pharmaceutically acceptable salt, or mixture thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.

Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.

Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.

Abstract: There is provided a curable composition comprising (A) a cyclic olefin; (B) a metathesis catalyst for polymerizing the cyclic olefin; (C) 0.1-30 wt. % of a compound comprising at least one vinyl group; and (D) 0.1-10 wt. % of a curing agent for compound (C), wherein the wt. % are relative to the total weight of the composition. The composition provides a desirable combination of workability, toughness and heat resistance. Also provided is a molded article comprising the composition and reinforcing fibers, and a method of manufacturing the same.

Abstract: The invention relates to a telecommunications system comprising at least a plurality of SA-cells. The invention provides a method for a terminal to facilitate establishment of a data connection between the terminal and at least one of the SA-cells. The method includes steps of, while the terminal is in an idle mode, the terminal transmitting an information request message (IRM) for the plurality of SA-cells and receiving, from each SA-cell of one or more SA-cells of the plurality of SA-cells, a message comprising at least information indicative of a strength with which the each SA-cell received the IRM. The method further includes the step of, at least partially based on the messages received from the one or more SA-cells, the terminal selecting an SA-cell of the plurality of SA-cells for establishing the data connection between the terminal and the selected SA-cell.

Abstract: Provided are, inter alia, multispecific antigen binding proteins, or antigen-binding fragments thereof, comprising one or more mutations in the VH/VL domains and/or CH1/CL domains, pharmaceutical compositions comprising same, isolated nucleic acids, vectors, and host cells encoding/expressing same, method of making the multispecific antigen binding proteins, computer readable media for evaluating multispecific antigen binding proteins, and libraries.

Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.

Abstract: The invention relates to shaped catalyst bodies for the oxidation of SO2 to SO3, which comprise vanadium, at least one alkali metal and sulfate on a silicon dioxide support material, wherein the shaped body has the shape of a cylinder having 3 or 4 hollow-cylindrical convexities, obtainable by extrusion of a catalyst precursor composition comprising vanadium, at least one alkali metal and sulfate on a silicon dioxide support material through the opening of an extrusion tool, wherein the opening of the extrusion tool has a cross section formed by 3 or 4 partly overlapping rings whose midpoints lie essentially on a circular line having a diameter of y, wherein the rings are bounded by an outer line lying on a circle having an external diameter x1 and an inner line lying on a circle having an internal diameter x2.

Abstract: The invention relates to a telecommunications system comprising at least a plurality of SA-cells. The invention provides a method for a terminal to facilitate establishment of a data connection between the terminal and at least one of the SA-cells. The method includes steps of, while the terminal is in an idle mode, the terminal transmitting an information request message (IRM) for the plurality of SA-cells and receiving, from each SA-cell of one or more SA-cells of the plurality of SA-cells, a message comprising at least information indicative of a strength with which the each SA-cell received the IRM. The method further includes the step of, at least partially based on the messages received from the one or more SA-cells, the terminal selecting an SA-cell of the plurality of SA-cells for establishing the data connection between the terminal and the selected SA-cell.

Abstract: The present invention relates to sizing compositions, to glass fibers at least partially coated with such sizing compositions, to a variety of fiber glass products at least partially coated with such sizing compositions, and to composites formed from cycloolefins and reinforced with glass fibers at least partially coated with sizing compositions of the present invention. In one non-limiting embodiment, a sizing composition for glass fibers comprises a film-former comprising a polymer, wherein the repeating unit of the polymer comprises at least four carbon atoms and at least one carbon-carbon double bond, and a silane.

Abstract: The present invention relates to sizing compositions, glass fibers at least partially coated with sizing compositions, and glass fiber reinforced composite materials. In one embodiment, a sizing composition comprises at least one maleic anhydride copolymer, at least one coupling agent, and a reaction product of an alkoxylated amine and a polycarboxylic acid, which is further reacted with an epoxy compound.

Abstract: There is provided a curable composition comprising (A) a cyclic olefin; (B) a metathesis catalyst for polymerizing the cyclic olefin; (C) 0.1-30 wt. % of a compound comprising at least one vinyl group; and (D) 0.1-10 wt. % of a curing agent for compound (C), wherein the wt. % are relative to the total weight of the composition. The composition provides a desirable combination of workability, toughness and heat resistance. Also provided is a molded article comprising the composition and reinforcing fibers, and a method of manufacturing the same.

Abstract: The invention provides compounds of Formula 1: or a stereoisomer, pharmaceutically acceptable salt, or mixture thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.

Abstract: The invention provides compounds of Formula XXIII: wherein R1 is hydrogen, alkyl, acyl, or silyl, R2 is hydrogen, alkyl, benzyl, acyl, or ester, and R3 is hydrogen, alkyl, an aromatic group, azacyclic, carbocycle, aryl, cycloalkyl, heterocycloalkyl, heterocycle, heteroaryl, heteroalkyl, acyl, or ester, as well as derivatives and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.

Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.

Abstract: The invention provides compounds of Formula 1: and stereoisomers, pharmaceutically acceptable salts and derivatives thereof; and methods of making and using such compounds. The invention includes pharmaceutical compositions containing such compounds, and the use of such compounds in methods of treating conditions, diseases, or disorders.

Abstract: Method for determining a parameter which is indicative for whether a patient is delirious or not, or is at risk of becoming delirious or not, wherein the method comprises the steps of: —providing electroencephalography (EEG) data comprising recording signals from at least two electrodes located on different locations on the patient's scalp during a predetermined time period, for instance at least 10 seconds, wherein at least one of the signals is recorded from the frontal half on the scalp; —processing said EEG data for obtaining a deviation signal from the two recording signals from the electrodes; —analyzing said deviation signal in the frequency spectrum for establishing slowing of said deviation signal and defining the parameter as the degree of slowing of said deviation signal which in combination with the locations of the recordings on the patient's scalp is indicative whether said patient is delirious or not, or is at risk of becoming delirious or not.

Abstract: The present invention provides sizing compositions and methods of using the same for glass fibers used in reinforced polymeric composites produced by reactive processing techniques.

Abstract: The invention relates to a telecommunications system comprising at least a plurality of SA-cells. The invention provides a method for a terminal to facilitate establishment of a data connection between the terminal and at least one of the SA-cells. The method includes steps of, while the terminal is in an idle mode, the terminal transmitting an information request message (IRM) for the plurality of SA-cells and receiving, from each SA-cell of one or more SA-cells of the plurality of SA-cells, a message comprising at least information indicative of a strength with which the each SA-cell received the IRM. The method further includes the step of, at least partially based on the messages received from the one or more SA-cells, the terminal selecting an SA-cell of the plurality of SA-cells for establishing the data connection between the terminal and the selected SA-cell.